Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Posts 30-Percent Revenue Increase, Narrowed Loss for Q2

NEW YORK, Nov 4 (GenomeWeb News) - Accelrys yesterday reported a 30-percent increase in revenues for its second fiscal quarter, accompanied by a 54-percent reduction in net losses. 


Revenue for the quarter ended Sept. 30 rose to $18.6 million from $14.3 million in the same quarter of 2004. The company attributed the increase in revenue to the impact of deferred revenue from its transition to subscription accounting last year.


Accelrys reported a net loss of $2.3 million, or $.09 per share, for the second quarter, compared to a net loss of $5.1 million, or $.21 per share, reported in the second quarter of 2004.


Product development costs rose slightly to $4.7 million for the second quarter, compared to $4.4 million in the year-ago period.


The company had $52.8 million in cash, restricted cash, cash equivalents, and marketable securities as of Sept. 30.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.